These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30190956)
21. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. Miura JT; Gamblin TC Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473 [TBL] [Abstract][Full Text] [Related]
22. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. Imai N; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Goto H World J Hepatol; 2014 Dec; 6(12):844-50. PubMed ID: 25544871 [TBL] [Abstract][Full Text] [Related]
23. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635 [TBL] [Abstract][Full Text] [Related]
24. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050 [TBL] [Abstract][Full Text] [Related]
25. Ablative and catheter-directed therapies for colorectal liver and lung metastases. Petre EN; Sofocleous CT; Solomon SB Hematol Oncol Clin North Am; 2015 Feb; 29(1):117-33. PubMed ID: 25475575 [TBL] [Abstract][Full Text] [Related]
26. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus Ludwig JM; Zhang D; Xing M; Kim HS Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480 [TBL] [Abstract][Full Text] [Related]
27. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. Facciorusso A; Licinio R; Muscatiello N; Di Leo A; Barone M World J Hepatol; 2015 Aug; 7(16):2009-19. PubMed ID: 26261690 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Mokkarala M; Noda C; Malone C; Ramaswamy R; Akinwande O Anticancer Res; 2019 Jun; 39(6):3071-3077. PubMed ID: 31177151 [TBL] [Abstract][Full Text] [Related]
29. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Vogl TJ; Zangos S; Eichler K; Yakoub D; Nabil M Eur Radiol; 2007 Apr; 17(4):1025-34. PubMed ID: 16944163 [TBL] [Abstract][Full Text] [Related]
33. New concepts in embolotherapy of HCC. Pesapane F; Nezami N; Patella F; Geschwind JF Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645 [TBL] [Abstract][Full Text] [Related]
34. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Tsochatzis EA; Germani G; Burroughs AK Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700 [TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis. Wei N; Zhang B; Wang Y; He XH; Xu LC; Li GD; Wang YH; Wang GZ; Huang HZ; Li WT Clin Transl Oncol; 2019 Apr; 21(4):443-450. PubMed ID: 30306400 [TBL] [Abstract][Full Text] [Related]